These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14719380)

  • 1. Complement and autoimmune glomerular diseases.
    Quigg RJ
    Curr Dir Autoimmun; 2004; 7():165-80. PubMed ID: 14719380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-mediated cellular injury.
    Takano T; Elimam H; Cybulsky AV
    Semin Nephrol; 2013 Nov; 33(6):586-601. PubMed ID: 24161043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic mechanisms of renal disease.
    Adler S; Couser W
    Am J Med Sci; 1985 Feb; 289(2):55-60. PubMed ID: 3883770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement and complement inhibitors: their role in autoimmune and inflammatory diseases.
    Sheerin NS; Sacks SH
    Curr Opin Nephrol Hypertens; 1998 May; 7(3):305-10. PubMed ID: 9617562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecules Great and Small: The Complement System.
    Mathern DR; Heeger PS
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1636-50. PubMed ID: 25568220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat.
    Schulze M; Baker PJ; Perkinson DT; Johnson RJ; Ochi RF; Stahl RA; Couser WG
    Kidney Int; 1989 Jan; 35(1):60-8. PubMed ID: 2651753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glomerular complement receptor in immunologically mediated renal glomerular injury.
    Gelfand MC; Shin ML; Nagle RB; Green I; Frank MM
    N Engl J Med; 1976 Jul; 295(1):10-4. PubMed ID: 1272284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular handling of immune complex in the acute phase of active in situ immune complex glomerulonephritis employing cationized ferritin in rats. Ultrastructural localization of immune complex, complements and inflammatory cells.
    Fujigaki Y; Nagase M; Kojima K; Yamamoto T; Hishida A
    Virchows Arch; 1997 Jul; 431(1):53-61. PubMed ID: 9247633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complement cascade and renal disease.
    Kościelska-Kasprzak K; Bartoszek D; Myszka M; Zabińska M; Klinger M
    Arch Immunol Ther Exp (Warsz); 2014 Feb; 62(1):47-57. PubMed ID: 24030732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition of the lectin pathway of complement in renal biopsies of lupus nephritis patients.
    Nisihara RM; Magrini F; Mocelin V; Messias-Reason IJ
    Hum Immunol; 2013 Aug; 74(8):907-10. PubMed ID: 23639552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of complement in glomerular injury.
    Feucht HE
    Kidney Blood Press Res; 1996; 19(5):290-9. PubMed ID: 8956241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of immune-deposit formation and the mediation of immune renal injury.
    Nangaku M; Couser WG
    Clin Exp Nephrol; 2005 Sep; 9(3):183-91. PubMed ID: 16189625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of complement in autoimmune renal disease.
    Seelen MA; Daha MR
    Autoimmunity; 2006 Aug; 39(5):411-5. PubMed ID: 16923541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The possibilities and pitfalls for anti-complement therapies in inflammatory diseases.
    Mizuno M; Morgan BP
    Curr Drug Targets Inflamm Allergy; 2004 Mar; 3(1):87-96. PubMed ID: 15032645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human C3b receptor (CR1).
    Weiss L; Fischer E; Haeffner-Cavaillon N; Jouvin MH; Appay MD; Bariety J; Kazatchkine M
    Adv Nephrol Necker Hosp; 1989; 18():249-69. PubMed ID: 2522267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of glomerular C3b receptors in human renal diseases.
    Colasanti G; Moran J; Bellini A; D'Amico G
    Ren Physiol; 1980; 3(1-6):387-94. PubMed ID: 6459626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis.
    Clynes R; Dumitru C; Ravetch JV
    Science; 1998 Feb; 279(5353):1052-4. PubMed ID: 9461440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of complement-derived mediators in inflammatory skin diseases.
    Tagami H
    Arch Dermatol Res; 1992; 284 Suppl 1():S2-9. PubMed ID: 1285651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of complement components in renal disease.
    Johnson RJ
    Curr Opin Nephrol Hypertens; 1997 Mar; 6(2):120-7. PubMed ID: 9146972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical applications of recombinant complement inhibitors].
    Lipiński D; Pławski A; Juzwa W; Zeyland J; Słomski R
    Pol Merkur Lekarski; 2004 Jun; 16(96):571-5. PubMed ID: 15510900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.